KC Biotech Company Gets $3 Million Federal Grant

Kansas City-based ImpeDx Diagnostics, which is developing a technology that will rapidly diagnose sepsis, has received a $3 million grant from the National Institutes of Health to help make the prototype it needs for clinical testing. CEO Steve O’Connor said the company will need to raise another $1 million to $2 million to fund the clinical testing.

O’Connor is a serial entrepreneur — this is his twelfth company, and he said he’s raised more than $120 million in his career — so he’s not worried about getting together the remaining funds. O’Connor said it always surprises people when he tells them sepsis — a severe blood infection — kills more people annually than breast and lung cancer combined.

Read more from the Kansas City Business Journal


Tags:, , , ,

Leave a Reply

Have you heard?

Missouri Business Alert is participating in CoMoGives2019!

Find out how we plan to use your gift to enhance training and programming for our students